Tenax Therapeutics, Inc. · NASDAQ:TENX
T. Rowe Price Associates Inc reported a 11.00% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)
Event Apr 30, 2026 · Filed May 7, 2026
T. Rowe Price Associates Inc reported a 11.00% stake in Tenax Therapeutics, Inc., 2,841,114 shares, as a passive investor on Apr 30, 2026. Filed May 7, 2026 (Schedule 13G/A).
- Stake
- 11.00%
- Shares
- 2,841,114
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 11.00% | 2,841,114 |
Source
Related
- Tenax Therapeutics, Inc.
- T. Rowe Price Associates Inc
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Associates Inc · Jun 5, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · May 7, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026